Skip to content

Home Non-invasive Ventilation for Chronic Obstructive Pulmonary Disease Patients

Home Non-invasive Ventilation Versus Long-term Oxygen Therapy in COPD Survivors of Acute Hypercapnic Respiratory Failure. A Multicenter Randomized Controlled Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01526642
Acronym
NIVOLD
Enrollment
12
Registered
2012-02-06
Start date
2011-12-31
Completion date
2015-12-31
Last updated
2017-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, Hypercapnic Respiratory Failure

Brief summary

Chronic Obstructive Pulmonary disease (COPD) patients with chronic hypercapnic respiratory failure are more likely to develop exacerbations. Non-invasive ventilation has been proposed to treat acute respiratory failure but little information is available about the benefits of home non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure surviving an acute hypercapnic respiratory failure. The purpose of this study is to determine whether home non-invasive ventilation can reduce recurrent acute hypercapnic respiratory failure in COPD patients who survived an episode of acute hypoxemic respiratory failure (AHRF) treated by Non-invasive ventilation (NIV).

Interventions

DEVICENon Invasive Ventilation

NIV during night

Sponsors

University Hospital, Rouen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years old * COPD patients who survived after an episode of acute hypercapnic respiratory failure * Patients weaned from ventilation (non invasive ventilation or mechanical ventilation) for acute episode since at least seven days with stable arterial blood gas since at least two days: PaCO2 \> 55 mmHg and pH \> 7.35

Exclusion criteria

* Age \> 85 years old * Non- COPD causes of respiratory failure * Obstructive sleep apnea excluded by polysomnography * Adverse psychosocial status * Serious co-morbidity

Design outcomes

Primary

MeasureTime frame
Acute hypercapnic respiratory failure episodeup to 102 weeks

Secondary

MeasureTime frame
Death1 month and every 6 months during 2 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026